HIV感染者双倍剂量乙肝疫苗免疫应答的系统综述与meta分析
该研究对9项随机临床试验共970例HIV阳性受种者进行系统综述与meta分析,比较双倍剂量与标准剂量乙肝疫苗的应答率。结果显示双倍剂量显著提高应答率,接种完成后4-6周和超过12个月测定的合并OR分别为1.76(95%CI:1.36-2.29)和2.28(95%CI:1.73-3.01),总OR为1.99(95%CI:1.64-2.41),未发现异质性。
要点
- HIV感染者双倍剂量乙肝疫苗应答率显著高于标准剂量
- 接种后4-6周与超过12个月测定均显示双倍剂量应答更优
- 合并OR为1.99(95%CI:1.64-2.41),研究间无异质性
核心结论
- 双倍剂量乙肝疫苗可能显著改善HIV感染者的免疫应答。
研究设计与样本
- 系统综述与随机临床试验meta分析,纳入9项研究共970例HIV阳性受种者,采用固定效应模型并进行异质性与敏感性分析。
主要发现
- 接种完成后4-6周测定应答率,双倍剂量对比标准剂量的合并OR为1.76(95%CI:1.36-2.29)。
- 接种完成后超过12个月测定应答率,双倍剂量对比标准剂量的合并OR为2.28(95%CI:1.73-3.01)。
- 总合并OR为1.99(95%CI:1.64-2.41),未发现异质性。
临床怎么用
- 对HIV感染者接种乙肝疫苗时,可考虑采用双倍剂量以提高免疫应答率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The prevalence of co-infection of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is high and increases risk of hepatitis B chronicity and mortality. Despite guidelines for HIV-infected patients to be immunized against HBV, the immunogenicity of the HBV vaccination in HIV-infected patients is lower than that in the HIV-seronegative population. METHOD: In this study, we performed a systematic review of the literature and meta-analysis of randomized clinical trials to investigate the response rate to an increased dose of HBV vaccination in HIV-infected patients. A fixed-effects model, with heterogeneity and sensitivity analyses, was used. We identified nine studies involving 970 HIV-positive vaccine recipients. RESULTS: The study results were divided into two groups, depending on the time when antibody against hepatitis surface antigen was measured. Results showed a significant increase in response rates among patients who received a double dose of the vaccine versus the standard dose in both subgroups; the pooled odds ratio (OR) was 1.76 (95% confidence interval [CI]: 1.36-2.29) and 2.28 (95% CI: 1.73-3.01) for the rate that was measured 4-6 weeks and >12 months after completion of vaccination, respectively. The total OR was 1.99 (95% CI: 1.64-2.41). No heterogeneity was found. DISCUSSION: Our meta-analysis shows that a double dose of the HBV vaccine may significantly improve the immune response in HIV-infected patients. Higher immunogenicity was observed, when it was measured 4-6 weeks and >12 months after completion of the vaccination.
引用
- Lee JH, Hong S, Im JH, et al. Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients. Vaccine. 2020. PMID: 32334887. doi:10.1016/j.vaccine.2020.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。